Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Pharmacol ; 659(2-3): 102-7, 2011 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-21453700

RESUMO

Astrocytes have been shown to release factors that affect various aspects of neuronal development. We have previously shown that the acetylcholine analog carbachol, by activating muscarinic M(3) receptors in rat astrocytes, increases their ability to promote neuritogenesis in hippocampal neurons. This effect was mediated by an increased expression and release by astrocytes of several permissive factors, a most relevant of which was fibronectin. In the present study we investigated the signal transduction pathways involved in these effects of carbachol in astrocytes. Results show that multiple pathways are involved in the effects of carbachol on astrocyte-mediated increases in fibronectin expression and neuritogenesis. These include the phospholipase D pathway, leading to sequential activation of protein kinase C (PKC) ζ, p70S6 kinase and nuclear factor-κB; the phosphoinositide-3 kinase pathway; and the PKC ε pathway leading to activation of mitogen activated protein kinase. These pathways were shown to mediate the effect of carbachol on neurite outgrowth as well as the increased expression of fibronectin, further substantiating the important role of the latter in astrocyte-mediated neuritogenesis. Interference with these signaling pathways would be expected to impair astrocyte-neurons communication leading to impaired neuronal development.


Assuntos
Astrócitos/citologia , Astrócitos/metabolismo , Hipocampo/citologia , Neuritos/metabolismo , Receptores Muscarínicos/metabolismo , Transdução de Sinais , Animais , Astrócitos/efeitos dos fármacos , Carbacol/farmacologia , Fibronectinas/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Neuritos/efeitos dos fármacos , Ratos , Transdução de Sinais/efeitos dos fármacos
2.
Glia ; 58(12): 1395-406, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20648635

RESUMO

In utero alcohol exposure can lead to fetal alcohol spectrum disorders, characterized by cognitive and behavioral deficits. In vivo and in vitro studies have shown that ethanol alters neuronal development. We have recently shown that stimulation of M(3) muscarinic receptors in astrocytes increases the synthesis and release of fibronectin, laminin, and plasminogen activator inhibitor-1, causing neurite outgrowth in hippocampal neurons. As M(3) muscarinic receptor signaling in astroglial cells is strongly inhibited by ethanol, we hypothesized that ethanol may also inhibit neuritogenesis in hippocampal neurons induced by carbachol-stimulated astrocytes. In the present study, we report that the effect of carbachol-stimulated astrocytes on hippocampal neuron neurite outgrowth was inhibited in a concentration-dependent manner (25-100 mM) by ethanol. This effect was because of the inhibition of the release of fibronectin, laminin, and plasminogen activator inhibitor-1. Similar effects on neuritogenesis and on the release of astrocyte extracellular proteins were observed after the incubation of astrocytes with carbachol in the presence of 1-butanol, another short-chain alcohol, which like ethanol is a competitive substrate for phospholipase D, but not by tert-butanol, its analog that is not a substrate for this enzyme. This study identifies a potential novel mechanism involved in the developmental effects of ethanol mediated by the interaction of ethanol with cell signaling in astrocytes, leading to an impairment in neuron-astrocyte communication.


Assuntos
Astrócitos/metabolismo , Depressores do Sistema Nervoso Central , Etanol/farmacologia , Neuritos/efeitos dos fármacos , Neurônios/citologia , Receptores Muscarínicos/metabolismo , Animais , Astrócitos/efeitos dos fármacos , Butanóis/farmacologia , Carbacol/farmacologia , Células Cultivadas , Córtex Cerebral/citologia , Agonistas Colinérgicos/farmacologia , Técnicas de Cocultura/métodos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Embrião de Mamíferos , Ensaio de Imunoadsorção Enzimática/métodos , Fibronectinas/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/citologia , Laminina/metabolismo , Microscopia Confocal/métodos , Modelos Biológicos , Neuritos/metabolismo , Neurônios/efeitos dos fármacos , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Ratos , Tubulina (Proteína)/metabolismo
3.
Alcohol Clin Exp Res ; 33(11): 1945-55, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19673741

RESUMO

BACKGROUND: In utero alcohol exposure can lead to fetal alcohol spectrum (FAS) disorders characterized by cognitive and behavioral deficits. In vivo and in vitro studies have shown that ethanol alters neuronal development. One mechanism through which ethanol has been shown to exert its effects is the perturbation of activated signaling cascades. The cholinergic agonist carbachol has been shown to induce axonal outgrowth through intracellular calcium mobilization, protein kinase C (PKC) activation, and ERK1/2 phosphorylation. This study investigated the effect of ethanol on the differentiation of rat hippocampal pyramidal neurons induced by carbachol as a possible mechanism involved in the developmental neurotoxicity of ethanol. METHODS: Prenatal rat hippocampal pyramidal neurons were treated with ethanol (50 to 75 mM) in the presence or absence of carbachol for 24 hours. Neurite outgrowth was assessed spectrophotometrically; axonal length was measured in neurons fixed and immunolabeled with the neuron-specific betaIII tubulin antibody; cytotoxicity was analyzed using the thiazolyl blue tetrazolium bromide assay. The effect of ethanol on carbachol-stimulated intracellular calcium mobilization was assessed utilizing the fluorescent calcium probe, Fluo-3AM. The PepTag(R) assay for nonradioactive detection of PKC from Promega was used to measure PKC activity, and ERK1/2 activation was determined by densitometric analysis of Western blots probed for phospo-ERK1/2. RESULTS: Ethanol treatment (50 to 75 mM) caused an inhibition of carbachol-induced axonal growth, without affecting neuronal viability. Neuron treatment for 15 minutes with ethanol did not inhibit the carbachol-stimulated rise in intracellular calcium, while inhibiting PKC activity at the highest tested concentration and ERK1/2 phosphorylation at both the concentrations used in this study. On the other hand, neuron treatment for 24 hours with ethanol significantly inhibited carbachol-induced increase in intracellular calcium. CONCLUSIONS: Ethanol inhibited carbachol-induced neurite outgrowth by inhibiting PKC and ERK1/2 activation. These effects may be, in part, responsible for some of the cognitive deficits associated with in utero alcohol exposure.


Assuntos
Axônios/fisiologia , Depressores do Sistema Nervoso Central/farmacologia , Etanol/farmacologia , Hipocampo/citologia , Neurônios/fisiologia , Receptores Muscarínicos/efeitos dos fármacos , Animais , Astrócitos/efeitos dos fármacos , Astrócitos/fisiologia , Axônios/efeitos dos fármacos , Western Blotting , Cálcio/metabolismo , Carbacol/farmacologia , Células Cultivadas , Corantes , Meios de Cultivo Condicionados , Feminino , Hipocampo/efeitos dos fármacos , Imuno-Histoquímica , Agonistas Muscarínicos/farmacologia , Neuritos/efeitos dos fármacos , Neuritos/ultraestrutura , Neurônios/efeitos dos fármacos , Sistema Nervoso Parassimpático/efeitos dos fármacos , Gravidez , Proteína Quinase C/metabolismo , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos , Sais de Tetrazólio , Tiazóis
4.
Toxicol Appl Pharmacol ; 240(2): 226-35, 2009 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-19524604

RESUMO

Manganese (Mn) is a known neurotoxicant and developmental neurotoxicant. As Mn has been shown to accumulate in astrocytes, we sought to investigate whether Mn would alter astrocyte-neuronal interactions, specifically the ability of astrocytes to promote differentiation of neurons. We found that exposure of rat cortical astrocytes to Mn (50-500 microM) impaired their ability to promote axonal and neurite outgrowth in hippocampal neurons. This effect of Mn appeared to be mediated by oxidative stress, as it was reversed by antioxidants (melatonin and PBN) and by increasing glutathione levels, while it was potentiated by glutathione depletion in astrocytes. As the extracellular matrix protein fibronectin plays an important role in astrocyte-mediated neuronal neurite outgrowth, we also investigated the effect of Mn on fibronectin. Mn caused a concentration-dependent decrease of fibronectin protein and mRNA in astrocytes lysate and of fibronectin protein in astrocyte medium; these effects were also antagonized by antioxidants. Exposure of astrocytes to two oxidants, H2O2 and DMNQ, similarly impaired their neuritogenic action, and led to a decreased expression of fibronectin. Mn had no inhibitory effect on neurite outgrowth when applied directly onto hippocampal neurons, where it actually caused a small increase in neuritogenesis. These results indicate that Mn, by targeting astrocytes, affects their ability to promote neuronal differentiation by a mechanism which is likely to involve oxidative stress.


Assuntos
Astrócitos/efeitos dos fármacos , Comunicação Celular/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Cloretos/toxicidade , Hipocampo/efeitos dos fármacos , Neurogênese/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Animais , Antioxidantes/farmacologia , Astrócitos/metabolismo , Astrócitos/patologia , Axônios/efeitos dos fármacos , Axônios/patologia , Células Cultivadas , Córtex Cerebral/embriologia , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Técnicas de Cocultura , Relação Dose-Resposta a Droga , Fibronectinas/genética , Fibronectinas/metabolismo , Glutationa/metabolismo , Hipocampo/embriologia , Hipocampo/metabolismo , Hipocampo/patologia , Compostos de Manganês , Neuritos/efeitos dos fármacos , Neuritos/patologia , Neurônios/metabolismo , Neurônios/patologia , Oxidantes/farmacologia , Estresse Oxidativo/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos
5.
J Pharmacol Exp Ther ; 329(2): 532-42, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19190235

RESUMO

Muscarinic receptors have been proposed to play an important role during brain development by regulating cell survival, proliferation, and differentiation. This study investigated the effect of muscarinic receptor activation on prenatal rat hippocampal pyramidal neuron differentiation and the signal transduction pathways involved in this effect. The cholinergic agonist carbachol, after 24 h in vitro, increased the length of the axon, without affecting the length of minor neurites. Carbachol-induced axonal growth was also observed in pyramidal neurons from the neocortex but not in granule neurons from the cerebellum. The effect of carbachol was mediated by the M(1) subtype of muscarinic receptors. The Ca(2+) chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, the two protein kinase C (PKC) inhibitors 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 2-[8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridol[1,2-a]indol-3-yl]-3-(1-methylindol-3-yl)maleimide (Ro-32-0432), and the extracellular signal-regulated kinase (ERK)1/2 inhibitors 2'-amino-3'-methoxyflavone (PD98059) and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) all blocked carbachol-induced axonal outgrowth. In addition, down-regulation of ERK1/2 with small interfering RNA abolished the neuritogenic effect of carbachol. These data suggest an involvement of Ca(2+), PKC, and ERK1/2 in carbachol-induced axonal growth. Carbachol indeed increased the release of Ca(2+) from intracellular stores and induced PKC and ERK1/2 activation. Additional experiments showed that PKC, but not Ca(2+), is involved in carbachol-induced ERK1/2 activation. Together, these results show that cholinergic stimulation of prenatal hippocampal pyramidal neurons accelerates axonal growth through the induction of Ca(2+) mobilization and the activation of PKC and especially of ERK1/2.


Assuntos
Diferenciação Celular , Células Piramidais/citologia , Receptor Muscarínico M1/metabolismo , Animais , Astrócitos/citologia , Astrócitos/efeitos dos fármacos , Cálcio/metabolismo , Carbacol/farmacologia , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Cerebelo/citologia , Cerebelo/embriologia , Cerebelo/metabolismo , Agonistas Colinérgicos/farmacologia , Hipocampo/citologia , Hipocampo/embriologia , Hipocampo/metabolismo , Masculino , Neocórtex/citologia , Neocórtex/embriologia , Neocórtex/metabolismo , Neuritos/efeitos dos fármacos , Neuritos/ultraestrutura , Neurônios/citologia , Neurônios/efeitos dos fármacos , Proteína Quinase C/metabolismo , Células Piramidais/metabolismo , Ratos , Transdução de Sinais/efeitos dos fármacos
6.
J Neurochem ; 90(3): 646-53, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15255942

RESUMO

Inhibition of astrocyte proliferation has been suggested to be an important event in the developmental neurotoxicity associated with ethanol. We have previously shown that the acetylcholine analog carbachol induces astroglial cell proliferation through activation of muscarinic M3 receptors, and that ethanol strongly inhibits this effect by inhibiting activation of protein kinase C (PKC) zeta and its down-stream effector 70-kDa ribosomal S6 kinase (p70S6K). In this study, we investigated whether inhibition by ethanol of this signal transduction pathway in 1321N1 human astrocytoma cells may be due, at least in part, to inhibition of the formation of the PKC zeta activator phosphatidic acid (PA), which is formed by hydrolysis of phosphatidylcholine by phospholipase D (PLD). 1-Butanol, which is a substrate for PLD and inhibits PA formation, inhibited carbachol-induced cell proliferation and the underlying intracellular signaling, whereas its analog tert-butanol, which is a poor substrate for PLD, was much less effective. In addition, exogenous PAs were able to increase DNA synthesis and to activate PKC zeta and p70S6K. Furthermore, in carbachol-stimulated cells, ethanol increased the formation of phosphatidylethanol and inhibited the formation of PA. Taken together, these results indicate that PLD activation plays an important role in carbachol-induced astroglial cell proliferation by generating the second messenger PA, which activates PKC zeta. Moreover, the effect of ethanol on carbachol-induced proliferation appears to be mediated, at least in part, by its ability to interact with PLD leading to a decreased synthesis of PA.


Assuntos
Astrocitoma/metabolismo , Carbacol/farmacologia , DNA/biossíntese , Etanol/farmacologia , Fosfolipase D/metabolismo , Transdução de Sinais/fisiologia , 1-Butanol/farmacologia , Astrocitoma/tratamento farmacológico , Astrocitoma/enzimologia , Divisão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Agonistas Colinérgicos/farmacologia , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Humanos , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Ácidos Fosfatídicos/metabolismo , Ácidos Fosfatídicos/farmacologia , Fosforilação/efeitos dos fármacos , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Proteínas Quinases S6 Ribossômicas 70-kDa/antagonistas & inibidores , Proteínas Quinases S6 Ribossômicas 70-kDa/metabolismo , Transdução de Sinais/efeitos dos fármacos , terc-Butil Álcool/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...